In mammary carcinoma cells expressing high levels of FABP5, FABP5 delivers RA to PPARβ/δ, enhances the transcriptional activity of PPARβ/δ and activates PPARβ/δ target gene, PDK1 and VEGF-A [41, 42]. The gene discussed is FABP5; the disease is breast carcinoma.